Literature DB >> 1376435

Biochemical heterogeneity in xeroderma pigmentosum complementation group E.

S Keeney1, H Wein, S Linn.   

Abstract

Cells from two patients with xeroderma pigmentosum complementation group E (XP-E) have been shown to lack an activity which binds specifically to UV-irradiated DNA (Chu and Chang, 1988). We investigated the occurrence of this binding activity in cell strains from nine additional, unrelated XP-E patients and found that all but one of these strains contained normal levels of the binding protein. Furthermore, the binding activity from these XP-E strains was indistinguishable from that of normal controls in thermal stability, behavior on ion-exchange chromatography, and electrophoretic mobility of protein-DNA complexes, indicating that there were no gross structural alterations in the protein. The association of XP-E with a deficiency in DNA-damage binding protein in cells from 3 of 12 XP-E patients (compared to 0 of 20 non-XP-E controls) is statistically significant (p less than 0.05), but there is no obvious correlation between the biochemical defect and the clinical or cellular characteristics of individual patients. Implications of these findings for the role of the binding protein in XP-E are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376435     DOI: 10.1016/0921-8777(92)90049-9

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  23 in total

1.  Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis.

Authors:  J Y Tang; B J Hwang; J M Ford; P C Hanawalt; G Chu
Journal:  Mol Cell       Date:  2000-04       Impact factor: 17.970

2.  DNA damage in the nucleosome core is refractory to repair by human excision nuclease.

Authors:  R Hara; J Mo; A Sancar
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Basal transcriptional regulation of human damage-specific DNA-binding protein genes DDB1 and DDB2 by Sp1, E2F, N-myc and NF1 elements.

Authors:  Anne F Nichols; Toshiki Itoh; Francesca Zolezzi; Stephanie Hutsell; Stuart Linn
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

4.  Interaction between UV-damaged DNA binding activity proteins and the c-Abl tyrosine kinase.

Authors:  Feng Cong; Jean Tang; Byung Joon Hwang; Bao Q Vuong; Gilbert Chu; Stephen P Goff
Journal:  J Biol Chem       Date:  2002-07-09       Impact factor: 5.157

5.  Relationship of the xeroderma pigmentosum group E DNA repair defect to the chromatin and DNA binding proteins UV-DDB and replication protein A.

Authors:  V Rapić Otrin; I Kuraoka; T Nardo; M McLenigan; A P Eker; M Stefanini; A S Levine; R D Wood
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

6.  p48 Activates a UV-damaged-DNA binding factor and is defective in xeroderma pigmentosum group E cells that lack binding activity.

Authors:  B J Hwang; S Toering; U Francke; G Chu
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

7.  Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair.

Authors:  B J Hwang; J M Ford; P C Hanawalt; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

8.  A novel role for DNA photolyase: binding to DNA damaged by drugs is associated with enhanced cytotoxicity in Saccharomyces cerevisiae.

Authors:  M E Fox; B J Feldman; G Chu
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

9.  Drosophila damage-specific DNA-binding protein 1 (D-DDB1) is controlled by the DRE/DREF system.

Authors:  Kei-ichi Takata; Gen Ishikawa; Fumiko Hirose; Kengo Sakaguchi
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

10.  Functional complementation of xeroderma pigmentosum complementation group E by replication protein A in an in vitro system.

Authors:  A Kazantsev; D Mu; A F Nichols; X Zhao; S Linn; A Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.